Video

Dr. Raje on Remaining Questions in Multiple Myeloma

Noopur S. Raje, MD, discusses remaining questions in multiple myeloma. 

Noopur S. Raje, MD, professor of medicine at Harvard Medical School and director of the Multiple Myeloma Program at Massachusetts General Hospital, discusses remaining questions in multiple myeloma. 

On the heels of recent advances with BCMA-directed therapies, future research efforts should focus on developing novel combination​s and ​refining sequencing strategies, says Raje. 

Additionally, smoldering myeloma remains an area of controversy, Raje explains. ​Eliminating the definition of smoldering myeloma, and instead focusing on whether a patient has myeloma, could help streamline the treatment algorithm.

Ultimately, better risk stratification is critical, Raje concludes. 

Related Videos
Meletios (Thanos) Dimopoulos, MD, professor, therapeutics, Hematology Oncology, National and Kapodistrian University of Athens School of Medicine
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Paul Chinfai Lee, MD, discusses the role of surgeons in regard to molecular testing in non–small cell lung cancer.
Neal D. Shore, MD, FACS
Sheldon M. Feldman, MD
Louis Crain Garrot, MD
Michel Delforge, MD, PhD
Thach-Giao Truong, MD
Aparna Parikh, MD
Benjamin P. Levy, MD, with Kristie Kahl and Andrew Svonavec